[tp_search_shortcodes id=1 origin="" destination="SYX" hotel_city="Sanya, China, 893, 26285, city, China" type="avia_hotel" subid=""]
[tp_in_our_city_fly_shortcodes destination=SYX title="" limit=100 paginate=true stops=0 one_way=false subid="" currency="USD"]
[tp_hotelmap_widget coordinates="18.252756, 109.513926" width=500 height=500 zoom=12 subid=""][tp_ducklett_widget responsive=true limit=9 type=slider filter=0 subid=""]
Data revealed in Global Health Progress' (GHP) new fact sheet shows that China is projected to become one of the world's major biopharmaceutical players, along with the U.S., Europe, and Japan, in the next fifteen years. This projection is based on China's commitment to improving access to healthcare by expanding its biotechnology sector, increasing its exportation of biopharmaceuticals and investing in pharmaceutical research and development (R&D).
Â
China has one of the fastest growing economies in the world with a gross domestic product of more than $ 8 trillion. Its biotechnology sector has become a bright spot in the Asia Pacific region and the world markets, with an impressive average annual growth rate of 19.4% between 2000 and 2005, and is anticipated to become the world's third-largest pharmaceutical market in 2011, a major increase over its #8 rank in 2000
Â
Part of China's successful growth is due to its decision to improve access to healthcare by increasing exports of biopharmaceuticals. For example, in 2006 China exported a total of US $ 890 million in biopharmaceuticals - a 30.61% increase compared with the previous year. China has also become the largest vaccine manufacturing country in the world, capable of producing 41 vaccines to prevent 26 viral diseases, and has become the third country to succeed in large-scale production of genetically engineered insulin.
Â
Additionally, China's pharmaceutical R&D expenditures are expected to reach US $ 10 billion or 2% of global spending by the end of 2010. The country is expected to contribute an additional $ 40+ billion in annual sales by 2013, comparable to the level of increased sales forecast for the US market in the same period.
Â
China's investment in the biotechnology sector has translated into improvements regarding access to healthcare and the country's economic growth through creating high-quality, highly skilled jobs. Currently, there are more than 500 biotechnology companies in China with the biopharmaceutical sector employing approximately 50,000 people. Additionally, pharmaceutical R&D is taking the form of multinational biopharmaceutical companies setting up research facilities in biotechnology parks in China, which can drive highly-skilled, high wage job growth and encourage better access to healthcare.
Global Health Progress supports efforts to raise awareness and mobilize resources to address health challenges, including supporting the development of tomorrow's medicines and improving access to healthcare.
People who search for Cheap Flights To Sanya also searches for :
cheap flights to sanya
cheap flights sanya
sanya travel guide
sanya travel
travel to sanya
travel sanya
sanya china travel
cheap flights to china
cheap flights china
cheap china flights
cheap flights to shanghai china
china travel
travel t o china
travel to china
china travel guide
travel china guide
travel china
china travel service
china travel tips
travel in china
travel i n china
china travel visa
flights to
flights to los angeles
los angeles flights
los angeles airfare
lax flights
flights from lax
airline tickets
flights from los angeles
los angeles cheap flights
los angeles tickets
last minute flights
cheap flights to los angeles
cheap flights to las vegas
cheap flights to san francisco
cheap flights to
cheap flights to rome
cheap flights to orlando
cheap flights to cancun
https://flightsglobal.net/ghp-fact-sheet-projects-china-to-become-major-biopharmaceutical-player/
Become, Biopharmaceutical, China, Fact, Major, Player, Projects, Sheet
No comments:
Post a Comment